Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)
Clinical trial NCT04409509 · COMPLETED
Trial details
- NCT number
- NCT04409509
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2021-01-12
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.